Indications and Purposes
| 1 Indications And Usage Luxturna (Voretigene Neparvovec-Rzyl) Is An Adeno-Associated Virus Vector-Based Gene Therapy Indicated For The Treatment Of Patients With Confirmed Biallelic Rpe65 Mutation-Associated Retinal Dystrophy. Patients Must Have Viable Retinal Cells As Determined By The Treating Physician(S). Luxturna Is An Adeno-Associated Virus Vector-Based Gene Therapy Indicated For The Treatment Of Patients With Confirmed Biallelic Rpe65 Mutation-Associated Retinal Dystrophy. Patients Must Have Viable Retinal Cells As Determined By The Treating Physician(S). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Voretigene Neparvovec-Rzyl |